Search Within

Genitourinary Oncology Service

Formats
  1. Journal Article (2792)
  2. Meeting Abstract (2524)
  3. Review (119)
  4. Book Section (83)
  5. Editorial (57)
  6. Correspondence (34)
  7. Conference Paper (29)
  8. Guidelines (25)
  9. Research Letter (18)
  10. Book Whole (4)
  11. Miscellaneous (4)
Groups
  1. Solid Tumor Oncology Division (5689)
  2. Department of Medicine (5679)
  3. GSK Faculty (1658)
  4. Human Oncology and Pathogenesis Program (1157)
  5. Department of Pathology and Laboratory Medicine (1129)
  6. Surgery (1021)

More Groups

People
  1. Robert Motzer (1252)
  2. Howard Scher (1133)
  3. David Solit (785)
  4. Dean Bajorin (663)
  5. Michael Morris (587)
  6. Jonathan Rosenberg (525)

More People

Years
  1. 2025 (198)
  2. 2024 (293)
  3. 2023 (283)
  4. 2022 (314)
  5. 2021 (341)
  6. 2020 (352)

More Years

Publications
  1. Journal of Clinical Oncology (1713)
  2. Annals of Oncology (304)
  3. Clinical Cancer Research (283)
  4. Cancer Research (245)
  5. Cancer (125)
  6. European Urology (121)

More Publications

Publishers
  1. American Society of Clinical Oncology (1780)
  2. American Association for Cancer Research (689)
  3. Oxford University Press (413)
  4. Elsevier Science, Inc. (394)
  5. Elsevier Inc. (380)
  6. Nature Publishing Group (302)

More Publishers

Results (5689)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Enfortumab vedotin plus pembrolizumab in previously untreated advanced urothelial cancer
    Journal Article

    Hoimes, C. J.; Flaig, T. W.; Milowsky, M. I.; Friedlander, T. W.; Bilen, M. A.; Gupta, S.; Srinivas, S.; Merchan, J. R.; McKay, R. R.; Petrylak, D. P.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Durvalumab plus olaparib in previously untreated, platinum-ineligible patients with metastatic urothelial carcinoma: A multicenter, randomized, phase II trial (BAYOU)
    Journal Article

    Rosenberg, J. E.; Park, S. H.; Kozlov, V.; Dao, T. V.; Castellano, D.; Li, J. R.; Mukherjee, S. D.; Howells, K.; Dry, H.; Lanasa, M. C.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Efficacy and safety of erdafitinib in adults with cholangiocarcinoma (CCA) with prespecified fibroblast growth factor receptor alterations (FGFRalt) in the phase 2 open-label, single-arm RAGNAR trial: Expansion cohort results
    Meeting Abstract

    Pant, S.; Schuler, M. H.; Iyer, G.; Doi, T.; Qin, S.; Tabernero, J.; Arnold, D.; Gutierrez, M.; Prenen, H.; Folprecht, G.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Clinical outcomes for IDH1 mutant biliary tract cancer (BTC) treated with contemporary systemic therapy
    Meeting Abstract

    Cowzer, D.; Huq, R.; Perry, M.; Keane, F.; Park, W.; El Dika, I. H.; Khalil, D.; Shia, J.; Sigel, C. S.; Bandlamudi, C.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Association of body mass index with the safety profile of nivolumab with or without ipilimumab
    Journal Article

    McQuade, J. L.; Hammers, H.; Furberg, H.; Engert, A.; AndreĢ, T.; Blumenschein, G. Jr; Tannir, N.; Baron, A.; Larkin, J.; El-Khoueiry, A.; more...
    JAMA Oncology (2023)

    Fulltext@MSK | Save
  • BLOODPAC: Collaborating to chart a path towards blood-based screening for early cancer detection
    Editorial

    Clarke, C. A.; Lang, K.; Putcha, G.; Beer, J. P.; Champagne, M.; Ferris, A.; Godsey, J. H.; Grossman, R. L.; Hoyos, J. M.; Johann, D. J.; more...
    CTS-Clinical and Translational Science (2023)

    Fulltext@MSK | Save
  • Expanded genetic testing of GIST patients identifies high proportion of non-syndromic patients with germline alterations
    Journal Article

    Mandelker, D.; Marra, A.; Mehta, N.; Selenica, P.; Yelskaya, Z.; Yang, C.; Somar, J.; Mehine, M.; Misyura, M.; Basturk, O.; more...
    npj Precision Oncology (2023)

    Fulltext@MSK | Save
  • Cost savings and increased access with ultra-low-dose immunotherapy
    Editorial

    Mitchell, A. P.; Goldstein, D. A.
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Adjuvant nivolumab versus placebo following radical surgery for high-risk muscle-invasive urothelial carcinoma: A subgroup analysis of Japanese patients enrolled in the phase 3 CheckMate 274 trial
    Journal Article

    Tomita, Y.; Kobayashi, K.; Kimura, G.; Oya, M.; Uemura, H.; Nishiyama, H.; Galsky, M. D.; Nasroulah, F.; Collette, S.; Broughton, E.; more...
    Japanese Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Predicting outcomes in female germ cell tumors using a modified International Germ Cell Cancer Collaborative Group classification system to guide management
    Journal Article

    Liu, Y. L.; Manning-Geist, B. L.; Knezevic, A.; Deng, L.; Bromberg, M.; Funt, S. A.; Meisel, J. L.; Zivanovic, O.; Roche, K. L.; Sonoda, Y.; more...
    Gynecologic Oncology (2023)

    Fulltext@MSK | Save